Now I have sufficient comprehensive information to compile a thorough, well-structured clinical answer. Let me now deliver the full response.
Approach to Gross Hematuria in a 70-Year-Old Male
This is a high-risk presentation that demands a structured, urgent urologic workup. In a male >50 years with gross hematuria, bladder cancer must be excluded first - it is the most common cause in this demographic. The cancer detection rate in gross hematuria is ~23-40%, far higher than in microscopic hematuria (3-5%).
Step 1 - Confirm True Hematuria
Before anything else, rule out pseudohematuria:
- Obtain a clean midstream urine sample
- Send for microscopic urinalysis (not just urine dipstick)
- Dipstick: sensitivity 91-100% but specificity only 65% - can be falsely positive with myoglobinuria, hemoglobinuria, beet ingestion, rifampicin, phenazopyridine
- Confirm RBCs on microscopy (>3 RBCs/HPF = confirmed hematuria)
Also examine RBC morphology:
- Dysmorphic/crenated RBCs + RBC casts = glomerular origin (nephrology referral)
- Normal/isomorphic RBCs = lower urinary tract / non-glomerular bleeding (urologic workup)
Step 2 - Focused History
Key questions to ask:
| Feature | Significance |
|---|
| Timing in stream (initial, total, terminal) | Initial = urethral/prostatic; Terminal = bladder neck/trigone; Total = kidney/ureter/bladder |
| Clots present? Shape? | Vermiform (worm-shaped) clots = upper tract; Cuboid clots = bladder |
| Pain? | Painless gross hematuria = bladder cancer until proven otherwise; Colicky flank pain = urolithiasis |
| Smoking history | Major risk factor for urothelial carcinoma |
| Occupational/chemical exposure | Aromatic amines, benzidine, aniline dyes - urothelial carcinogens |
| LUTS (frequency, urgency, dysuria) | Irritative symptoms can suggest CIS (carcinoma in situ) |
| Anticoagulant/antiplatelet use | Does NOT cause hematuria per se - full workup still required |
| Prior pelvic radiation | Risk for radiation cystitis + secondary malignancy |
| Cyclophosphamide use | Hemorrhagic cystitis / bladder cancer risk |
| Weight loss, anorexia | Systemic malignancy |
| Family history of GU cancers | Urothelial, RCC, Lynch syndrome |
Note: Anticoagulation use does NOT eliminate the need for full workup - hematuria on anticoagulation still requires complete urologic evaluation.
Step 3 - Physical Examination
- BP - hypertension may suggest glomerular disease
- Abdominal exam - palpable renal mass (RCC), pulsatile mass (AAA - life-threatening, must not be missed)
- Abdominal bruit - arteriovenous fistula
- CVA (costovertebral angle) tenderness - pyelonephritis, calculi
- Digital Rectal Exam (DRE) - prostate size, nodularity (10% of recurrent gross hematuria has prostate cancer)
- Genital exam - meatal/urethral lesion, perineal trauma
Step 4 - Initial Investigations
Urine
| Test | Purpose |
|---|
| Urine microscopy + culture | Confirm RBCs; exclude UTI (treat first if UTI, but if hematuria persists after treatment, full workup still needed) |
| Urine cytology | Recommended in gross hematuria (can detect high-grade urothelial carcinoma, CIS) |
| Spot urine protein:creatinine | If glomerular origin suspected |
Blood
| Test | Purpose |
|---|
| CBC | Anaemia, thrombocytopenia |
| RFTs (Creatinine, eGFR) | Renal function baseline |
| PT/INR, aPTT | Coagulopathy |
| PSA | In males - 10% of recurrent gross hematuria cases have prostate cancer |
| Serum electrolytes | Baseline |
Step 5 - Imaging (Upper Tract)
CT Urography (CTU) - Investigation of Choice
- Multi-phase CT: non-contrast + nephrographic + excretory (delayed) phase
- Best overall imaging for gross hematuria - detects:
- Urothelial tumors of renal pelvis and ureter
- Renal cell carcinoma
- Urolithiasis
- Hydronephrosis
- Renal cysts, trauma
- Detects ~90% of upper tract malignant lesions
- Standard of care per AUA guidelines for gross hematuria
If contrast contraindicated (allergy, poor renal function): MR Urography is an acceptable alternative
Renal-bladder ultrasound alone is not sufficient for gross hematuria (acceptable substitute only in low-risk microhematuria).
Step 6 - Cystoscopy (Mandatory)
- All patients with gross hematuria require cystoscopy - no imaging modality can adequately evaluate the bladder mucosa
- CT urography is not as sensitive as cystoscopy for bladder urothelial tumors
- Flexible cystoscopy preferred as an office procedure
- Allows direct visualization of:
- Bladder tumors (papillary, sessile, CIS)
- Bladder neck, trigone
- Ureteral orifices (looking for lateralizing hematuria - blood jetting from one orifice = upper tract lesion)
- Prostatic urethra
- Urethra
Step 7 - Special Considerations for This Patient (70M, No Comorbidities)
This patient is high risk by all stratification systems:
- Age >60 (strongest independent risk factor)
- Male sex
- Any episode of gross hematuria = automatic high-risk category regardless of other factors
Per the 2025 AUA/SUFU Guideline (updated from 2020):
- Any gross hematuria triggers complete urologic evaluation: CTU + cystoscopy + urine cytology
- Do NOT defer or watch - every episode must be investigated
- Even one negative urinalysis after gross hematuria does NOT eliminate need for workup
Differential Diagnosis (Most to Least Likely in This Context)
| Priority | Cause | Notes |
|---|
| 1st | Bladder urothelial carcinoma | Most common cause of gross hematuria in men >50; 85% present with painless hematuria |
| 2nd | Renal cell carcinoma | Hematuria + flank pain + mass = classic triad (rarely all 3 present) |
| 3rd | Urolithiasis | Usually with colicky pain; clots may be present |
| 4th | Upper tract urothelial carcinoma | Renal pelvis/ureter; vermiform clots |
| 5th | BPH with prostate bleeding | Increased prostate vascularity; but must exclude malignancy |
| 6th | Prostate cancer | DRE + PSA |
| 7th | Radiation/hemorrhagic cystitis | History usually clarifies |
| 8th | Glomerulonephritis / IgA nephropathy | Dysmorphic RBCs, casts, proteinuria, HTN |
| 9th | Renal infarction / AVM | Less common |
| 10th | AAA / vascular | Rare but life-threatening - pulsatile mass = urgent imaging |
Diagnostic Algorithm Summary
Gross Hematuria (70Y Male)
↓
Rule out pseudohematuria (urine microscopy)
↓
Confirm UTI? → Treat → Re-check → If persists → Full workup
↓
History + Physical + DRE + PSA
↓
Labs: CBC, RFTs, coagulation, urine cytology, urine culture
↓
CT Urography (upper tract imaging)
↓
Cystoscopy (mandatory, regardless of CTU findings)
↓
├─ Mass/filling defect on CTU → Urologic oncology referral
├─ Bladder tumor on cystoscopy → TURBT + staging
├─ Lateralizing hematuria from ureteral orifice → Retrograde pyelogram + ureteroscopy
└─ All negative → Consider nephrology referral (glomerular workup)
Key Clinical Pearls
- Painless gross hematuria in a male >50 = bladder cancer until proven otherwise
- Even a single episode must be fully investigated - hematuria is often intermittent
- Anticoagulation is not an excuse to skip workup - it does not cause hematuria, it unmasks it
- Risk of malignancy on gross hematuria evaluation: ~20-40% vs 3-5% for microscopic hematuria
- 85% of newly diagnosed bladder cancers present with painless gross hematuria
- PSA should be considered - 10% of recurrent gross hematuria cases have prostate cancer
- If negative workup: low risk of malignancy for next 3-5 years, but any new gross hematuria triggers repeat full evaluation
Sources: Campbell Walsh Wein Urology 3-Volume Set, p. 96-106 | ROSEN's Emergency Medicine, p. 1920-1980 | Campbell Walsh Wein Urology, p. 4571-4575 (Detection of Urothelial Carcinoma) | AUA/SUFU Microhematuria Guideline 2025 | AUA Medical Student Curriculum: Hematuria